Hologic

ASPR's IBx Portfolio​

Contract 1: 

Product: Tests

Description of Project: This investment will enable Hologic, Inc. to expand production capacity for COVID-19 tests in their supplier’s facilities, increasing their production capacity to 13 million COVID-19 tests per month by January 2022.

Unique Impact: This investment will enable Hologic to improve the supply to laboratories across the country in addition to scaling up employment in Hologic supplier facilities and support the demand for COVID-19 testing in the United States.

Base Award Amount: $7,506,725.76

Category: Testing Capacity and Raw Materials

Contract 2: 

Product: Tests

Description of Project: This investment will further enable Hologic, Inc. to expand production capacity for COVID-19 tests.

Unique Impact: This investment will enable Hologic to improve the supply to laboratories across the country in addition to scaling up employment in Hologic supplier facilities and support the demand for COVID-19 testing in the United States.

Base Award Amount: $119,426,577.30

Category: Testing Capacity and Raw Materials